EH
SGMO

Equitable Holdings’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Equitable Holdings’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.4K Buy
+12,848
New +$5.11K ﹤0.01% 1686

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Equitable Holdings's SGMO Position: Q1 2026 in Review

Equitable Holdings opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026: 12,848 shares worth $5.4K. The stake represents ﹤0.01% of the portfolio and ranks #1686 among its holdings.

112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Equitable Holdings held 12,848 shares of SANGAMO THERAPEUTICS INC worth $5.4K as of Q1 2026.
  • SANGAMO THERAPEUTICS INC was a new Equitable Holdings position in Q1 2026.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Equitable Holdings's portfolio in Q1 2026, its #1686 holding.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.